◼ Archived
Business
🔮 fades ✗
Novartis inks $3.2B subcutaneous delivery deal with Alteogen
Novartis has entered a multi-billion dollar agreement to utilize Alteogen's subcutaneous drug delivery technology.
1 trends tracked about this subject — the full history, oldest to newest below.
Novartis has entered a multi-billion dollar agreement to utilize Alteogen's subcutaneous drug delivery technology.